VIPoma
VIPoma
Images
Definition
VIPoma is a very rare type of cancer that usually grows from certain cells in the pancreas.
Alternative Names
Vasoactive intestinal peptide-producing tumor; Pancreatic endocrine tumor
Causes, incidence, and risk factors
VIPoma causes cells in the pancreas to produce high levels of a hormone called vasoactive intestinal peptide (VIP). This hormone increases secretions from the intestines and relaxes some of the smooth muscles in the GI system.
The cause is not known.
VIPomas are usually diagnosed in adults, most commonly at age 50. Women are more likely to be affected than men. This cancer is rare, affecting an estimated 1 in 10 million people per year.
Symptoms
- Abdominal pain and cramping
- Flushing or redness of the face
- Nausea
- Watery diarrhea (often massive amounts)
- Weight loss
Signs and tests
Signs may include:
- Dehydration
- High volume of diarrhea (even without eating)
- Low stomach acid (achlorhydria)
- Low blood potassium (hypokalemia), which can cause leg cramps
Tests include:
- CT scan
- MRI
- Stool examination for cause of diarrhea and electrolyte levels
- Vasoactive intestinal peptide (VIP) in the blood
Treatment
The first goal of treatment is to correct dehydration. Fluids are often given through a vein (intravenous fluids) to replace fluids lost in diarrhea.
The next goal is to slow the diarrhea. Some medications can help control diarrhea. Ocreotide, which is a man-made form of a natural hormone, blocks the action of VIP.
The best chance for a cure is surgery to remove the tumor. If the tumor has not spread to other organs, surgery can often cure it.
Expectations (prognosis)
Surgery can usually cure VIPomas. However, in one-third to one-half of patients, the tumors have spread by the time of diagnosis and are not curable.
Complications
- Cancer spread (metastasis)
- Cardiac arrest from electrolyte imbalances
- Dehydration
Calling your health care provider
If you have watery diarrhea for more than 2-3 days, call your doctor.
References
Jensen RT, Norton JA. Endocrine tumors of the pancreas and gastrointestinal tract. In: Feldman M, Friedman LS, Brandt LJ, eds. Sleisenger & Fordtran's Gastrointestinal and Liver Disease. 8th ed. Philadelphia, Pa: Saunders Elsevier; 2006:chap 31.
Review Date: 9/4/2008
Reviewed by: Sean O. Stitham, MD, private practice in Internal Medicine, Seattle, Washington; and James R. Mason, MD, Oncologist, Director, Blood and Marrow Transplantation Program and Stem Cell Processing Lab, Scripps Clinic, Torrey Pines, California. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
A.D.A.M., Inc. is accredited by URAC,
also known as the American Accreditation HealthCare Commission (www.urac.org). URAC'saccreditation
program is an independent audit to verify that A.D.A.M. follows rigorousstandards of quality and
accountability. A.D.A.M. is among the first to achieve this important distinction for online health
information andservices. Learn more about A.D.A.M.'s editorialpolicy,
editorialprocess,
and privacypolicy.
A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net
Foundation (www.hon.ch.)
The information provided herein should not be used during any medical emergency or
for the diagnosis or treatmentof any medical condition. A licensed medical professional should be consulted
for diagnosis and treatment of any and all medical conditions.Call 911 for all medical emergencies. Links to
other sites are provided for information only -- they do not constitute endorsements of thoseother sites.
©1997-2006 A.D.A.M., Inc. Any duplication ordistribution of the
information contained herein is strictly prohibited.
